查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493354

美国血液诊断市场规模、份额、趋势分析报告：按产品类型、按测试类型、按最终用途、按地区、细分市场预测，2024-2030 年

U.S. Hematology Diagnostics Market Size, Share & Trends Analysis Report By Product (Instrument, Consumable), By Test Type, By End-use (Hospital, Diagnostic Lab), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10个工作天内

价格

美国血液诊断市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，美国血液诊断市场规模预计将达到30.7亿美元，2024年至2030年复合年增长率为5.3%。

癌症盛行率的增加是市场成长的主要因素之一。根据美国癌症协会统计，2021年有超过190万人新诊断出癌症，同年有超过60万人死于癌症。因此，癌症诊断药物的需求预计将扩大。

此外，技术进步彻底改变了血液检测系统，使检测变得更简单，减轻了患者的痛苦。随着血液相关疾病的研发投资不断增加，血液诊断的未来性充满希望。由于医疗保健支出的增加和对提高诊断能力的日益关注，预计血液诊断市场在预测期内将显着增长。

血液相关疾病盛行率的上升是支持美国血液诊断市场成长的关键因素。这个市场扩张主要是由新兴研究工作推动的，这些研究工作探索血液学诊断在早期检测各种类型癌症中的有效性。根据白血病和淋巴瘤协会估计，2023年将有约59,610人被诊断出患有白血病，美国报告的白血病新病例约为1,958,310例。

美国血液诊断市场报告亮点：

  • 按产品划分，预计到 2023 年，消耗品将以 65% 左右的份额主导市场，并在预测期内实现最快的复合年增长率。血液诊断耗材是诊断实验室和医疗机构日常业务的关键组成部分。这些耗材对于执行对患者护理至关重要的各种血液学测试和程序至关重要。
  • 按测试类型划分，白血球 (WBC) 测试领域预计将在 2023 年占据最大的市场占有率，并在预测期内实现最快的复合年增长率。市场对白血球 (WBC) 检测的需求主要是由于需要准确、快速地评估白血球计数和分类计数。该测试在美国市场的各种医疗状况的诊断和监测中发挥着重要作用，并已成为临床实践中的标准做法。
  • 按最终用途划分，医院细分市场将在 2023 年占据主导地位。另一方面，诊断实验室领域预计在预测期内将以最快的复合年增长率成长。血液检测实验室为诊断和管理血液疾病、感染疾病和其他健康状况提供准确可靠的结果，在医疗保健中发挥重要作用。它可以帮助医疗保健提供者根据测试结果做出有关患者护理的明智决策。所有因素都可能推动该细分市场的成长。
  • 2021 年，Illumina 推出了 TruSight Hematology Panel，次世代定序仪(NGS) 面板。这种创新的解决方案可实现全面的基因分析，为诊断和治疗提供宝贵的见解。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章美国血液诊断市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 美国血液诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国血液诊断市场：产品预估及趋势分析

  • 2023年及2030年产品市场占有率
  • 细分仪表板
  • 美国血液诊断市场的产品展望
  • 2018-2030年市场规模、预测及趋势分析
  • 装置
  • 消耗品

第五章美国血液诊断市场：测试类型估计和趋势分析

  • 2023 年和 2030 年测试类型市场占有率
  • 细分仪表板
  • 按测试类型分類的美国血液诊断市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 白血球测试
  • 红血球测试
  • 血红素测试
  • 血球容积比测试
  • 血小板功能

第六章美国血液诊断市场：最终用途估计与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 按最终用途分類的美国血液诊断市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 医院
  • 诊断实验室
  • 其他的

第七章美国血液诊断市场：区域估计与趋势分析

  • 2023 年和 2030 年按地区分類的市场占有率份额
  • 美国血液诊断市场按地区前景
  • 2018-2030年市场规模、预测及趋势分析
  • 西
  • 中西部
  • 东北
  • 西南
  • 东南

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
  • 公司简介
    • Abbott
    • Beckman Coulter
    • Sysmex Corporation
    • Horiba
    • Bio-Rad Laboratories
    • Siemens Healthcare
    • F. Hoffmann-La Roche Ltd.
    • Mindray
    • Nihon Kohden
    • EKF Diagnostics
Product Code: GVR-4-68040-284-4

U.S. Hematology Diagnostics Market Growth & Trends:

The U.S. hematology diagnostics market size is anticipated to reach USD 3.07 billion by 2030, expanding at a CAGR of 5.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of cancer is one of the primary factors contributing to the market growth. According to the American Cancer Society, Inc., in 2021, over 1.9 million new cancer cases were diagnosed, and over 600,000 people died from cancer in the same year. Hence, the demand for cancer diagnostics is expected to grow.

In addition, technological advancements have revolutionized blood testing systems, making them simpler and less painful for patients. The future of hematology diagnostics looks promising owing to increased investments in research and development focused on blood-related diseases. With rising healthcare expenditure and a growing focus on improving diagnostic capabilities, the market for hematology diagnostics is expected to experience significant growth in the forecast period.

The rising prevalence of blood-related conditions is a significant driver behind the growth of the hematology diagnostics market in the U.S. Expansion in this market is predominantly propelled by emerging research endeavors exploring the effectiveness of hematology diagnostics in the early identification of different types of cancers. According to estimates from the Leukemia & Lymphoma Society, in 2023, about 59,610 people are expected to be diagnosed with leukemia, and about 1,958,310 new cases of leukemia were reported in the U.S.

U.S. Hematology Diagnostics Market Report Highlights:

  • Based on product, consumables dominated the market with a share of around 65% in 2023 and are expected to register the fastest CAGR during the forecast period. Hematology diagnostic consumables are indeed crucial components in the daily functions of diagnostic labs and healthcare facilities. These consumables are integral to conducting various hematology tests and procedures essential for patient care
  • Based on test type, the white blood cell (WBC) test segment accounted for the largest market share in 2023 and is expected to register the fastest CAGR during the forecast period. The demand for White Blood Cell (WBC) testing in the market is primarily fueled by the need for precise and prompt evaluation of white and differential counts. This testing is a standard practice in clinical settings as it plays a crucial role in diagnosing and monitoring a wide range of medical conditions in the U.S. market
  • Based on end-use, the hospitals segment dominated the market in 2023. On the other hand, the diagnostic labs segment is projected to grow at the fastest CAGR over the forecast period. Blood testing laboratories play a vital role in healthcare by providing accurate and reliable results for diagnosing and managing blood disorders, infections, and other health conditions. They help healthcare providers make informed decisions about patient care based on the test results. All factors would drive the market segment's growth
  • In 2021, Illumina launched the TruSight Hematology Panel, a next-generation sequencing (NGS) panel designed to detect hematological disorders. This innovative solution enables comprehensive genetic analysis, providing valuable insights for diagnosis and treatment

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Instrument
    • 1.2.3. Test Type
    • 1.2.4. End-use
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product
    • 2.2.2. Instrument
    • 2.2.3. Test Type
    • 2.2.4. End-use
  • 2.3. Competitive Insights

Chapter 3. U.S. Hematology Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Hematology Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Hematology Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Technology Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Hematology Diagnostics Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 4.4.1. Instruments
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. Hematology Analyzers
      • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2.2. Clinical Laboratory Testing Hematology Analyzers
      • 4.4.1.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2.2.2. Point-Of-Care Testing Hematology Analyzers
      • 4.4.1.2.2.3. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. Flow Cytometers
      • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.4. Slide Stainers/Markers
      • 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Consumables
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Reagents
      • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Stains
      • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Controls and Calibrators
      • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Hematology Diagnostics Market: Test Type Estimates & Trend Analysis

  • 5.1. Test Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. Hematology Diagnostics Market by Test Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 5.4.1. White Blood Cells (WBC) Test
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Red Blood Cells (RBC) Test
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Hemoglobin Test
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Hematocrit Test
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Platelet Function
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Hematology Diagnostics Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. Hematology Diagnostics Market by End-use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 6.4.1. Hospitals
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Diagnostic Labs
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Others
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. U.S. Hematology Diagnostics Market: Region Estimates & Trend Analysis

  • 7.1. Regional Market Share, 2023 & 2030
  • 7.2. U.S. Hematology Diagnostics Market by Region Outlook
  • 7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 7.3.1. West
      • 7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Midwest
      • 7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Northeast
      • 7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.4. Southwest
      • 7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.5. Southeast
      • 7.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company heat map analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Beckman Coulter
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Sysmex Corporation
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Horiba
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Bio-Rad Laboratories
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Siemens Healthcare
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. F. Hoffmann-La Roche Ltd.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Mindray
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Nihon Kohden
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. EKF Diagnostics
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. hematology diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. hematology diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 4 U.S. hematology diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 U.S. hematology diagnostics market, by region, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. hematology diagnostics market outlook
  • Fig. 9 Hematology diagnostics competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. hematology diagnostics market driver impact
  • Fig. 14 U.S. hematology diagnostics market restraint impact
  • Fig. 15 U.S. hematology diagnostics market: Product movement analysis
  • Fig. 16 U.S. hematology diagnostics market: Product outlook and key takeaways
  • Fig. 17 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Consumables estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 U.S. hematology diagnostics market: Test type movement Analysis
  • Fig. 20 U.S. hematology diagnostics market: Test type outlook and key takeaways
  • Fig. 21 White blood cells (WBC) test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Red blood cells (RBC) test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Hemoglobin test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Hematocrit test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Platelet function market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. hematology diagnostics market: End-use movement Analysis
  • Fig. 27 U.S. hematology diagnostics market: End-use outlook and key takeaways
  • Fig. 28 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Diagnostic labs test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. hematology diagnostics market: Regional movement analysis
  • Fig. 32 U.S. hematology diagnostics market: Regional outlook and key takeaways
  • Fig. 33 West market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)